NO972303L - Intravenöse lubeluzollösninger - Google Patents
Intravenöse lubeluzollösningerInfo
- Publication number
- NO972303L NO972303L NO972303A NO972303A NO972303L NO 972303 L NO972303 L NO 972303L NO 972303 A NO972303 A NO 972303A NO 972303 A NO972303 A NO 972303A NO 972303 L NO972303 L NO 972303L
- Authority
- NO
- Norway
- Prior art keywords
- lubeluzole
- intravenous
- solutions
- solution
- adjust
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
En løsning for intravenøs administrasjon innehol- dende lubeluzol eller et farmasøytisk akseptabelt addisjonssalt derav, et isotoniseringsmiddel, vann og syre og basesubstanser for å innstille pH-verdi- en i løsningen i området fra 2,5 til 3,6; fremgangsmåter ved deres fremstilling.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94203422 | 1994-11-24 | ||
PCT/EP1995/004520 WO1996015790A1 (en) | 1994-11-24 | 1995-11-16 | Lubeluzole intravenous solutions |
Publications (2)
Publication Number | Publication Date |
---|---|
NO972303L true NO972303L (no) | 1997-05-21 |
NO972303D0 NO972303D0 (no) | 1997-05-21 |
Family
ID=8217408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO972303A NO972303D0 (no) | 1994-11-24 | 1997-05-21 | Intravenöse lubeluzollösninger |
Country Status (19)
Country | Link |
---|---|
US (1) | US5744484A (no) |
EP (1) | EP0794777A1 (no) |
JP (1) | JPH10509712A (no) |
CN (1) | CN1166787A (no) |
AR (1) | AR002001A1 (no) |
AU (1) | AU693969B2 (no) |
BR (1) | BR9509821A (no) |
CA (1) | CA2205606A1 (no) |
CZ (1) | CZ155897A3 (no) |
FI (1) | FI972204A0 (no) |
HU (1) | HUT77390A (no) |
IL (1) | IL116102A (no) |
MX (1) | MX9703839A (no) |
NO (1) | NO972303D0 (no) |
PL (1) | PL320296A1 (no) |
SK (1) | SK65197A3 (no) |
TR (1) | TR199501482A1 (no) |
WO (1) | WO1996015790A1 (no) |
ZA (1) | ZA959995B (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SA96170106A (ar) * | 1995-07-06 | 2005-12-03 | أسترا أكتيبولاج | مشتقات حامض أميني جديدة |
WO1997015306A1 (en) * | 1995-10-25 | 1997-05-01 | Janssen Pharmaceutica N.V. | Infusions of neuroprotectants and perfluorochemicals |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5010198A (en) * | 1984-12-03 | 1991-04-23 | Janssen Pharmaceutica N.V. | Intermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agents |
CA1260474A (en) * | 1984-12-03 | 1989-09-26 | Raymond A. Stokbroekx | Benzoxazol- and benzothiazolamine derivatives |
ZW1992A1 (en) * | 1991-02-25 | 1993-09-22 | Janssen Pharmaceutica Nv | 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol |
-
1995
- 1995-11-16 PL PL95320296A patent/PL320296A1/xx unknown
- 1995-11-16 MX MX9703839A patent/MX9703839A/es unknown
- 1995-11-16 US US08/817,740 patent/US5744484A/en not_active Expired - Lifetime
- 1995-11-16 BR BR9509821A patent/BR9509821A/pt not_active Application Discontinuation
- 1995-11-16 EP EP95940191A patent/EP0794777A1/en not_active Withdrawn
- 1995-11-16 CA CA002205606A patent/CA2205606A1/en not_active Abandoned
- 1995-11-16 HU HU9702128A patent/HUT77390A/hu unknown
- 1995-11-16 SK SK651-97A patent/SK65197A3/sk unknown
- 1995-11-16 WO PCT/EP1995/004520 patent/WO1996015790A1/en not_active Application Discontinuation
- 1995-11-16 CZ CZ971558A patent/CZ155897A3/cs unknown
- 1995-11-16 JP JP8516550A patent/JPH10509712A/ja active Pending
- 1995-11-16 CN CN95196419A patent/CN1166787A/zh active Pending
- 1995-11-16 AU AU41729/96A patent/AU693969B2/en not_active Ceased
- 1995-11-23 AR ARP950100296A patent/AR002001A1/es unknown
- 1995-11-23 IL IL11610295A patent/IL116102A/xx active IP Right Grant
- 1995-11-23 ZA ZA959995A patent/ZA959995B/xx unknown
- 1995-11-24 TR TR95/01482A patent/TR199501482A1/xx unknown
-
1997
- 1997-05-21 NO NO972303A patent/NO972303D0/no not_active Application Discontinuation
- 1997-05-23 FI FI972204A patent/FI972204A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
CZ155897A3 (en) | 1997-10-15 |
AU693969B2 (en) | 1998-07-09 |
CA2205606A1 (en) | 1996-05-30 |
EP0794777A1 (en) | 1997-09-17 |
FI972204A (fi) | 1997-05-23 |
JPH10509712A (ja) | 1998-09-22 |
TR199501482A1 (tr) | 1996-10-21 |
FI972204A0 (fi) | 1997-05-23 |
AR002001A1 (es) | 1998-01-07 |
CN1166787A (zh) | 1997-12-03 |
WO1996015790A1 (en) | 1996-05-30 |
BR9509821A (pt) | 1997-10-21 |
ZA959995B (en) | 1997-05-23 |
AU4172996A (en) | 1996-06-17 |
MX9703839A (es) | 1997-08-30 |
IL116102A (en) | 2000-02-29 |
SK65197A3 (en) | 1997-12-10 |
US5744484A (en) | 1998-04-28 |
PL320296A1 (en) | 1997-09-15 |
IL116102A0 (en) | 1996-01-31 |
HUT77390A (hu) | 1998-04-28 |
NO972303D0 (no) | 1997-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054324L (no) | Anvendelse av ranolazin og minst ett pH-avhengig bindemiddel for fremstilling av ranolazinpreparater med depotvirkning | |
LU90297I2 (fr) | Rivastigmine ses sels et dérivés pharmaceutiquement acceptables en particulier la rivastigmine sous forme d'hydrogénotartrate | |
CA2201749A1 (en) | Stable aqueous alfa interferon solution formulations | |
UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
IL128036A (en) | Deoxynojirimycin derivatives comprising a polyclic alcohol group, pharmaceutical composition comprising a deoxynojirimycin derivative and uses thereof | |
GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
SE9503143D0 (sv) | New preparation | |
UA42779C2 (uk) | Фармацевтично стійкий препарат оксалату платини для парентерального застосування | |
ATE153022T1 (de) | 3',5'-ditertbutyl-4'-hydroxyflavone, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung mit antioxidations- und antivasokonstriktionsaktivität | |
ES2108129T3 (es) | Nuevos derivados de pirazina, su preparacion y empleo. | |
DK146786A (da) | 4'-demethyl-4-epipodophyllotoxinderivater, deres fremstilling og anvendelse i laegemidler, isaer som antitumormidler | |
DE69631542D1 (de) | Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen | |
HUT53664A (en) | Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
CA2000336A1 (en) | Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same | |
EP0800828A4 (en) | TRANSMUCOSAL PREPARATION | |
NO972303L (no) | Intravenöse lubeluzollösninger | |
IE802033L (en) | Dibenzazepine derivatives | |
ATE117313T1 (de) | Stabile lösungen von rebeccamycinderivaten sowie deren herstellung. | |
WO1990003172A3 (en) | Bile acids for treatment of viral infections | |
KR830004849A (ko) | 약학적 제제의 제조방법 | |
KR860002269A (ko) | 비경구용 액제의 제조방법 | |
DK0865422T3 (da) | Anvendelse af aminoalkoholderivater som lægemidler, hidtil ukendte derivater og fremgangsmåde til fremstilling deraf | |
KR900004713A (ko) | 디아민 유도체 및 그의 제조방법 | |
Senczuk et al. | Toxicodynamic properties of toluidines. Part V. Methaemoglobin-genic action of toluidines. | |
RU98114539A (ru) | Способ создания модели экспериментальной глаукомы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |